|Bid||0.00 x 120000|
|Ask||0.00 x 120000|
|Day's Range||95.00 - 95.00|
|52 Week Range||86.00 - 255.00|
|PE Ratio (TTM)||-1.94|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: Yahoo FinanceGet free summary analysis Akers Biosciences, Inc. reports financial results for the quarter ended March 31, 2017. Highlights Summary numbers: Revenues of GBP 0.54 million, Net Earnings of GBP -1.09 million. Gross margins narrowed from 67.10% to 54.81% compared to the same period last year, operating (EBITDA) margins now -195.04% from -197.89%. Change in operating ... Read more (Read more...)
NEW YORK, NY / ACCESSWIRE / May 16, 2017 / Akers Biosciences, Inc. (NASDAQ: AKER ) will be discussing their earnings results in their Q1 Earnings Call to be held May 16, 2017 at 9:00 AM Eastern Time. To ...
Akers Biosciences, Inc. , , a developer of rapid health information technologies, reports its financial results for the first quarter ended March 31, 2017.